Blueweave
Antimicrobial Susceptibility Testing Market Report

Global Antimicrobial Susceptibility Testing Market, By Product (Automated Laboratory Instruments, Manual Antimicrobial Susceptibility Testing Products, Culture and Growth Media, And Consumables); By Application (Clinical Diagnostics, Drug Discovery, and Development, Epidemiology, Other Applications); By Type (Antifungal Susceptibility Testing, Antibacterial Susceptibility Testing, Antiparasitic Susceptibility Testing, Other Susceptibility Testing Types); By Method (Disk Diffusion, ETEST Method, Automated Susceptibility Testing Instruments, Agar Dilution, Genotyping Methods) By End-User (Hospitals and Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, Clinical Research Organizations (CROs)); By Region (North America, Europe, the Asia-Pacific, the Middle East & Africa, and Latin America) Trend Analysis, Competitive Market Share & Forecast, 2017-2027

  • Published Date: June 2021
  • Report ID: bwc20388
  • Available Format: PDF
  • Page: 156

Report Overview

The Global Antimicrobial Susceptibility Testing Market- Industry Trends & Forecast Report 2027

The global antimicrobial susceptibility testing market was worth USD 3.19 billion in 2020 and is further projected to reach a valuation of USD 4.70 billion by 2027, at a CAGR of 5.9% during the forecast period (2021-2027). Antimicrobial resistance to bacterial infections, driven by an increase in resistant bacterial strains and antibiotic usage, is driving the global antimicrobial susceptibility testing market. The market is also gaining momentum due to the growing incorporation of rapid commercial AST (Antimicrobial Susceptibility Testing) systems to test fungal infections. Other significant factors like increased funding and government initiatives, surge in the incidences of infectious diseases globally, and the emergence of multidrug-resistant bacterial strains like Acinetobacter baumannii, MRSA, and Klebsiella pneumonia are considerably boosting the growth of the global antimicrobial susceptibility testing market.


Source: Blue Weave Consulting

Global Antimicrobial Susceptibility Testing Market Overview

Antimicrobial susceptibility testing or AST is a procedure performed under laboratory conditions to confirm the specific antibiotic regimen suitable for a particular patient, based on the type of infection and the bacterial strain infecting the patient. Thus, by performing this test, one can determine the sensitivity of a microbe to any particular antibiotic. An essential guideline in successful treatment has been the avoidance of over-medication with paradoxical worsening. Higher antibiotics like carbapenem, glycopeptide, oxazolidinone are usually reserved for the treatment of more severe infections. Instead, they are the "last line" agents to be used (Duplessis C, Cianflone N, 2011). Thus, to determine the infection and its suitable antibiotic regimen, the global antimicrobial susceptibility testing market is proliferating.

Global Antimicrobial Susceptibility Testing Market Trend

Growth Drivers

Growing Prevalence of Multidrug-Resistant Bacterial Strains

Human health is at risk as a result of the emergence of resistance to the most common bacterial diseases. The emergence of multidrug-resistant organisms in the hospital environment and community settings suggests that reservoirs of antibiotic-resistant bacteria are present even outside the hospital. Most antimicrobial agents are naturally produced molecules, and so co-resident bacteria have evolved mechanisms to overcome their action to survive. Thus, these organisms are often considered to be "intrinsically" resistant to one or more antimicrobial agents. Antibiotic resistance is among the three most important public health threats of the 21st century, as recommended by World Health Organization.

Antibiotic-resistant bacteria are an essentially unavoidable result of widespread antimicrobial usage, resulting in increased demand for the development of newer medications and antimicrobial susceptibility testing. Thus, due to such a significant threat, antimicrobial susceptibility testing has become imperative to treat microbial infection, to prevent paradoxical worsening of the patient's condition due to over-medication or under-medication. Antimicrobial susceptibility testing also plays a vital role in research to find out the multidrug-resistant strains and find the most effective therapeutic regimen for its treatment. Hence owing to this, the global antimicrobial susceptibility market is growing exponentially.

Increased Funding and Increasing Government Initiatives

Governments of different countries have been taking various measures to raise awareness regarding the effects of the overuse of antimicrobial agents to treat microbial infections. These initiatives by governments across the globe have been helpful in providing critical information to patients, doctors, and nurses about the prevention of the incidences of diseases. India, for example, launched the National Programme on Containment of Antimicrobial Resistance (2012-2017) in the country as part of its 12th five-year plan to establish a laboratory-based antimicrobial resistance (AR) surveillance system to raise awareness among healthcare providers about antimicrobial resistance. Such initiatives have been propelling the growth of the global antimicrobial susceptibility testing market.

Restraints

High Cost Involved in Automated Antimicrobial Susceptibility Testing Instruments

Because they have greatly expanded features and functionalities, automated antimicrobial susceptibility testing devices are quite costly and offered at premium rates. In comparison to manual antimicrobial testing approaches such as the disc diffusion technique, which requires manually inserting antibiotic-soaked discs on microbial-infected agar plates, the deployment of automated AST systems takes substantially less time. These automated testing kits reduce incubation time since they comprise cutting-edge techniques that mimic the environmental conditions of the host body for microbial growth. However, these improved technologies have a relatively high investment cost, which is a major impediment to their deployment, particularly for small-budget organizations.

Impact of COVID-19

Because to the COVID-19 epidemic, several industries have been caught off guard, and the global antimicrobial susceptibility testing market is no exceptionBillion. Because hospitals focused primarily on COVID -19 management at the start of the pandemic, the utilization of automated antimicrobial susceptibility testing devices such as the Accelerate Pheno system, MicroScan WalkAway, and Sensitive ARIS system was significantly reduced. Moreover, all other procedures and protocols were temporarily put on hold to focus on the COVID-19 pandemic and check the spread of the virus. Furthermore, tight regulatory measures such as lockdown and curfew had a negative impact on the global antimicrobial susceptibility testing market.

Global Antimicrobial Susceptibility Testing Market: By Product

The global antimicrobial susceptibility testing industry is categorized into automated laboratory instruments, culture and growth media, manual antimicrobial susceptibility testing products, and consumables based on the type of product. In the global antimicrobial susceptibility testing market, the manual susceptibility testing products segment holds the largest share. Manual antimicrobial susceptibility testing products comprise susceptibility testing disks, MIC strips, and susceptibility testing plates. The growing prevalence of antibacterial resistance, newer treatment protocols, affordability, and its small-scale application are the major factors contributing to this segment's growth.

Global Antimicrobial Susceptibility Testing Market: By Application

In terms of application, the global antimicrobial susceptibility testing market is segmented into clinical diagnostics, epidemiology, drug discovery & development, and other applications. Out of these, the clinical diagnostics segment accounted for the largest share of the global antimicrobial susceptibility testing market. The massive share can be attributed to the growing incidence of HAIs (Hospital-acquired infections), increasing cases of infectious diseases, and large target patient population volume, coupled with the early disease diagnosis across significant markets. The rising procedural volume of clinical diagnostic tests and the introduction of various technologically advanced susceptibility testing products also contribute to the market growth.

Global Antimicrobial Susceptibility Testing Market: By Type

Based on type, the global antimicrobial susceptibility testing market is segmented into antibacterial susceptibility testing, antiparasitic susceptibility testing, antifungal susceptibility testing, other susceptibility testing types.  The antibacterial susceptibility testing segment holds the largest share in the global antimicrobial susceptibility testing market. The significant share of this segment can be attributed to the emergence of multidrug-resistant strains like Klebsiella pneumonia, Acinetobacter baumanii. S. aureus, MRSA. These are some highly resistant bacteria that have developed severe resistance due to genetic mutations, which has led to the development of resistant systems, like the efflux pump system, which effectively shields the bacteria from antibiotic attacks.

Global Antimicrobial Susceptibility Testing Market: By Method

Based on method, the global antimicrobial susceptibility testing market is segmented into disk diffusion, agar dilution, automated susceptibility testing instruments, genotyping methods.  Out of these methods, the automated antimicrobial susceptibility testing instruments segment accounts for the largest share in the global antimicrobial susceptibility testing market. The segment's dominance can be attributed to crucial aspects such as accuracy, precision, and shortened time due to the absence of any incubation period. Moreover, it has the ability to simultaneously produce qualitative and quantitative susceptibility results. Also, technological enhancements and increasing investments in R&D by key players to deliver novel technologies are equally contributing to the growth of this segment.

Global Antimicrobial Susceptibility Testing Market: By Region

Based on type, the global antimicrobial susceptibility testing market is segmented into North America, Europe, the Asia-Pacific, the Middle East & Africa, and Latin America. Out of these regions, North America holds the lion’s share of the global antimicrobial susceptibility testing market. The growing investment in R&D to develop novel automated AST systems, technological advancements in antimicrobial susceptibility products, increasing cases of infectious diseases are some of the key factors supporting market growth in North America.

Source: Blue Weave Consulting

Competitive Landscape

The growing prevalence of infectious diseases, coupled with emerging multidrug-resistant bacterial strains and growing government initiatives, have made the global antimicrobial susceptibility testing market a very lucrative one. Stiff competition is present within the key players to develop better testing solutions for more accurate and quicker results to satisfy the end-users. Some of the major companies in the global antimicrobial susceptibility testing market are- PML Microbiologicals Inc., BioMérieux SA, QuantaMatrix Inc., MP Biomedicals, InvivoGen, Biotron Ltd, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation, Roche Diagnostics Limited, Bio-Rad Laboratories, Inc., Merck KGaA, Accelerate Diagnostics, Inc., Liofilchem S.r.l., ZHUHAI DL BIOTECH Co., Ltd., ELITechGroup, Halifax S.r.l., Hi-Media Laboratories, Genefluidics, Inc., Creative Diagnostics, and other prominent players.

Recent Developments

·         In March 2021, bioMérieux announced the launch of VIDAS TB-IGRA, which is the new fully automated assay intended to aid in the diagnosis of Mycobacterium tuberculosis infection. VIDAS TB-IGRA provides reliable test results and improves current workflow.

 

·         In May 2020, Liofilchem received the US FDA approval for the Lefamulin 0.016-256 μg/mL MTS (MIC Test Strip), a quantitative assay to be used to determine the minimum inhibitory concentration (MIC) of lefamulin.

Attribute

Details

Years Considered

Historical data – 2017-2020

Base Year – 2020

Forecast – 2021 – 2027

Facts Covered

Revenue in USD Million

Market Coverage

U.S, Canada, Germany, UK, France, Italy, Spain, Brazil, Japan, South Korea, China, India, UAE, South Africa, Saudi Arabia

Product/Service Segmentation

By Type, By The Method, By Application, By Product, By End-User, By Region

Key Players

PML Microbiologicals Inc., BioMérieux SA, QuantaMatrix Inc., MP Biomedicals, InvivoGen, Biotron Ltd, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation, Roche Diagnostics Limited, Bio-Rad Laboratories, Inc., Merck KGaA, Accelerate Diagnostics, Inc., Liofilchem S.r.l., ZHUHAI DL BIOTECH Co., Ltd., ELITechGroup, Halifax S.r.l., Hi-Media Laboratories, Genefluidics, Inc., Creative Diagnostics.

 

 

 

·         By Product

o    Manual Antimicrobial Susceptibility Testing Products

§  Susceptibility Testing Disks

§  MIC Strips

§  Susceptibility Testing Plates

o    Automated Laboratory Instruments

o    Culture and Growth Media

o    Consumables

·         By Application

o    Clinical Diagnostics

o    Drug Discovery and Development

o    Epidemiology

o    Other Applications

·         By End-User

o    Hospitals and Diagnostic Centers

o    Pharmaceutical and Biotechnology Companies

o    Research &Academic Institutes

o    Clinical Research Organizations (CROs)

·         By Type

o    Antibacterial Susceptibility Testing

o    Antifungal Susceptibility Testing

o    Antiparasitic Susceptibility Testing

o    Other Susceptibility Testing Types (slow-growing pathogens)

·         By Method

o    Test Method

o    Disk Diffusion

o    Automated Susceptibility Testing Instruments

o    Agar Dilution

o    Genotyping Methods

·         By Region

o    North America

o    Europe

o    The Asia-Pacific

o    Latin America

o    The Middle East and Africa

 

FAQs:

1.    What is the current size of the global antimicrobial susceptibility testing market?

Answer: The global antimicrobial susceptibility testing market reached USD XX billion in 2020.

 

2.    What are the major factors driving the growth of the global antimicrobial susceptibility testing market?

Answer: The growing prevalence of infectious diseases, coupled with emerging multidrug-resistant bacterial strains and growing government initiatives, has made the global antimicrobial susceptibility testing market a very lucrative one.

3.    Who are the key players in the global antimicrobial susceptibility testing market?

Answer: PML Microbiologicals Inc., BioMérieux SA, QuantaMatrix Inc., MP Biomedicals, InvivoGen, Biotron Ltd, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation, Roche Diagnostics Limited, Bio-Rad Laboratories, Inc., Merck KGaA, Accelerate Diagnostics, Inc., Liofilchem S.r.l., ZHUHAI DL BIOTECH Co., Ltd., ELITechGroup, Halifax S.r.l., Hi-Media Laboratories, Genefluidics, Inc., Creative Diagnostics.

4.    Which application accounted for the largest share in the global antimicrobial susceptibility testing market?

Answer: Clinical Diagnostics by application accounted for the largest share in the global antimicrobial susceptibility testing market.

5.    Which region is growing at a higher rate in the global antimicrobial susceptibility testing market?

Answer:  North America is growing at a higher rate in the global antimicrobial susceptibility testing market.


1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Research

2.2. Quantitative Research

2.3. Market Breakdown & Data Triangulation

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Region

2.5. Assumption & Limitation

3.    Executive Summary

4.    Global Antimicrobial Susceptibility Testing Market Insights

4.1. Industry Value Chain Analysis

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Recent Development/Technological Advancements

4.4. Porter’s Five Forces Analysis

4.4.1.   Bargaining Application of Suppliers

4.4.2.   Bargaining Application of Buyers

4.4.3.   Threat of New Entrants

4.4.4.   Threat of Substitutes

4.4.5.   Intensity of Rivalry

5.    Global Antimicrobial Susceptibility Testing Market Overview

5.1. Market Size & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast

5.2.1.   By Product

5.2.1.1.       Manual Antimicrobial Susceptibility Testing Products

5.2.1.1.1.        Susceptibility Testing Disks

5.2.1.1.2.        MIC Strips

5.2.1.1.3.        Susceptibility Testing Plates

5.2.1.2.       Automated Laboratory Instruments

5.2.1.3.       Culture and Growth Media

5.2.1.4.       Consumables

5.2.2.   By Application

5.2.2.1.       Clinical Diagnostics

5.2.2.2.       Drug Discovery and Development

5.2.2.3.       Epidemiology

5.2.2.4.       Other Applications

5.2.3.   By End-User

5.2.3.1.       Hospitals and Diagnostic Centers

5.2.3.2.       Pharmaceutical and Biotechnology Companies

5.2.3.3.       Research &Academic Institutes

5.2.3.4.       Clinical Research Organizations (CROs)

5.2.4.   By Type

5.2.4.1.       Antibacterial Susceptibility Testing

5.2.4.2.       Antifungal Susceptibility Testing

5.2.4.3.       Antiparasitic Susceptibility Testing

5.2.4.4.       Other Susceptibility Testing Types (slow-growing pathogens)

5.2.5.   By Method

5.2.5.1.       Etest Method

5.2.5.2.       Disk Diffusion

5.2.5.3.       Automated Susceptibility Testing Instruments

5.2.5.4.       Agar Dilution

5.2.5.5.       Genotyping Methods

5.2.6.   By Region

5.2.6.1.       North America

5.2.6.2.       Europe

5.2.6.3.       the Asia-Pacific

5.2.6.4.       Latin America

5.2.6.5.       the Middle East and Africa

6.    North America Antimicrobial Susceptibility Testing Market

6.1. Market Size & Forecast by Value, 2017-2027

6.1.1.   By Value (USD Million)

6.2. Market Share & Forecast

6.2.1.   By Product

6.2.2.   By Application

6.2.3.   By End-User

6.2.4.   By Type

6.2.5.   By Method

6.2.6.   By Country

6.2.6.1.     U.S.

6.2.6.2.     Canada

7.    Europe Antimicrobial Susceptibility Testing Market

7.1. Market Size & Forecast by Value, 2017-2027

7.1.1.   By Value (USD Million)

7.2. Market Share & Forecast

7.2.1.   By Product

7.2.2.   By Application

7.2.3.   By End-User

7.2.4.   By Type

7.2.5.   By Method

7.2.6.   By Country

7.2.6.1.       Germany

7.2.6.2.       United Kingdom

7.2.6.3.       Italy

7.2.6.4.       France

7.2.6.5.       Spain

7.2.6.6.       Rest of Europe

8.    the Asia-Pacific Antimicrobial Susceptibility Testing Market

8.1. Market Size & Forecast by Value, 2017-2027

8.1.1.   By Value (USD Million)

8.2. Market Share & Forecast

8.2.1.   By Product

8.2.2.   By Application

8.2.3.   By End-User

8.2.4.   By Type

8.2.5.   By Method

8.2.6.   By Country

8.2.6.1.     China

8.2.6.2.     India

8.2.6.3.     Japan

8.2.6.4.     Singapore

8.2.6.5.     South Korea

8.2.6.6.     Rest of Asia Pacific

9.    Latin America Antimicrobial Susceptibility Testing Market

9.1. Market Size & Forecast by Value, 2017-2027

9.1.1.   By Value (USD Million)

9.2. Market Share & Forecast

9.2.1.   By Product

9.2.2.   By Application

9.2.3.   By End-User

9.2.4.   By Type

9.2.5.   By Method

9.2.6.   By Country

9.2.6.1.     Brazil

9.2.6.2.     Argentina

9.2.6.3.     Columbia

9.2.6.4.     Mexico

9.2.6.5.     Rest of Latin America

10.the Middle East & Africa Antimicrobial Susceptibility Testing Market

10.1.     Market Size & Forecast by Value, 2017-2027

10.1.1.                By Value (USD Million)

10.2.     Market Share & Forecast

10.2.1.                By Product

10.2.2.                By Application

10.2.3.                By End-User

10.2.4.                By Type

10.2.5.                By Method

10.2.6.                By Country

10.2.6.1.      Saudi Arabia

10.2.6.2.      Iran

10.2.6.3.      UAE

10.2.6.4.      Turkey

10.2.6.5.      South Africa

10.2.6.6.      Rest of The Middle East & Africa

11.Competitive Landscape

11.1.   List of Key Players and Their Offerings

11.2.   Market Share Analysis, 2020

11.3.   Competitive Benchmarking, By Operating Parameters

12.Impact of Covid-19 on Global Antimicrobial Susceptibility Testing Industry

13.Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, SWOT Analysis, Contact Address, and Strategic Outlook) **

13.1.     PML Microbiologicals Inc.

13.2.     BioMérieux SA

13.3.     QuantaMatrix Inc.

13.4.     MP Biomedicals

13.5.     InvivoGen

13.6.     Biotron Ltd

13.7.     Becton, Dickinson and Company

13.8.     Thermo Fisher Scientific

13.9.     Danaher Corporation

13.10.  Roche Diagnostics Limited

13.11.  Bio-Rad Laboratories, Inc.

13.12.  Merck KGaA

13.13.  Accelerate Diagnostics, Inc.

13.14.  Liofilchem S.r.l.

13.15.  ZHUHAI DL BIOTECH Co., Ltd.

13.16.  ELITechGroup

13.17.  Alifax S.r.l.

13.18.  Hi-Media Laboratories

13.19.  Genefluidics, Inc.

13.20.  Creative Diagnostics

14.Key Strategic Recommendations

*Financial details of unlisted companies will be available as per data availability in final deliverable

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

List of Figures

Fig: Global Antimicrobial Susceptibility Testing Segmentation

Fig: Global Antimicrobial Susceptibility Testing Market Value Chain Analysis

Fig: Company Market Share Analysis, 2019

Fig: Global Antimicrobial Susceptibility Testing Market Size, By Value (USD Billion), 2017-2027

Fig: Global Antimicrobial Susceptibility Testing Market Share, By Product, By Value, 2017-2027

Fig: Global Antimicrobial Susceptibility Testing Market Share, By Application, By Value, 2017-2021

Fig: Global Antimicrobial Susceptibility Testing Market Share, By End-User, By Value, 2017-2027

Fig: Global Antimicrobial Susceptibility Testing Market Share, By Type, By Value, 2017-2027

Fig: Global Antimicrobial Susceptibility Testing Market Share, By Method, By Value, 2017-2027

 

Fig: Global Antimicrobial Susceptibility Testing Market Share, By Region, By Value, 2017-2027

Fig: North America Antimicrobial Susceptibility Testing Market Size, By Value (USD Billion), 2017-2027

Fig: North America Antimicrobial Susceptibility Testing Market Share, By Product, By Value, 2017-2027

Fig: North America Antimicrobial Susceptibility Testing Market Share, By Application, By Value, 2017-2027

Fig: North America Antimicrobial Susceptibility Testing Market Share, By End-User, By Value, 2017-2027

Fig: North America Antimicrobial Susceptibility Testing Market Share, By Type, By Value, 2017-2027

Fig: North America Antimicrobial Susceptibility Testing Market Share, By Method, By Value, 2017-2027

Fig: North America Antimicrobial Susceptibility Testing Market Share, By Country, By Value, 2017-2027

Fig: Europe Antimicrobial Susceptibility Testing Market Size, By Value (USD Billion), 2017-2027

Fig: Europe Antimicrobial Susceptibility Testing Market Share, By Product, By Value, 2017-2027

Fig: Europe Antimicrobial Susceptibility Testing Market Share, By Application, By Value, 2017-2027

Fig: Europe Antimicrobial Susceptibility Testing Market Share, By End-User, By Value, 2017-2027

Fig: Europe Antimicrobial Susceptibility Testing Market Share, By Type, By Value, 2017-2027

Fig: Europe Antimicrobial Susceptibility Testing Market Share, By Method, By Value, 2017-2027

Fig: Europe Antimicrobial Susceptibility Testing Market Share, By Country, By Value, 2017-2027

Fig: The Asia-Pacific Antimicrobial Susceptibility Testing Market Size, By Value (USD Billion), 2017-2027

Fig: The Asia-Pacific Antimicrobial Susceptibility Testing Market Share, By Product, By Value, 2017-2021

Fig: The Asia-Pacific Antimicrobial Susceptibility Testing Market Share, By Application, By Value, 2017-2027

Fig: The Asia-Pacific Antimicrobial Susceptibility Testing Market Share, By End-User, By Value, 2017-2027

Fig: The Asia-Pacific Antimicrobial Susceptibility Testing Market Share, By Type, By Value, 2017-2027

Fig: The Asia-Pacific Antimicrobial Susceptibility Testing Market Share, By Method, By Value, 2017-2027

Fig: The Asia-Pacific Antimicrobial Susceptibility Testing Market Share, By Country, By Value, 2017-2027

Fig: Latin America Antimicrobial Susceptibility Testing Market Size, By Value (USD Billion), 2017-2027

Fig: Latin America Antimicrobial Susceptibility Testing Market Share, By Product, By Value, 2017-2027

Fig: Latin America Antimicrobial Susceptibility Testing Market Share, By Application, By Value, 2017-2027

Fig: Latin America Antimicrobial Susceptibility Testing Market Share, By End-User, By Value, 2017-2027

Fig: Latin America Antimicrobial Susceptibility Testing Market Share, By Type, By Value, 2017-2027

Fig: Latin America Antimicrobial Susceptibility Testing Market Share, By Method, By Value, 2017-2027

Fig: Latin America Antimicrobial Susceptibility Testing Market Share, By Country, By Value, 2017-2027

Fig: The Middle East & Africa Antimicrobial Susceptibility Testing Market Size, By Value (USD Billion), 2017-2021

Fig: The Middle East & Africa Antimicrobial Susceptibility Testing Market Share, By Product, By Value, 2017-2027

Fig: The Middle East & Africa Antimicrobial Susceptibility Testing Market Share, By Application, By Value, 2017-2027

Fig: The Middle East & Africa Antimicrobial Susceptibility Testing Market Share, By End-User, By Value, 2017-2027

Fig: The Middle East & Africa Antimicrobial Susceptibility Testing Market Share, By Type, By Value, 2017-2027

Fig: The Middle East & Africa Antimicrobial Susceptibility Testing Market Share, By Method, By Value, 2017-2027

Fig: The Middle East & Africa Antimicrobial Susceptibility Testing Market Share, By Country, By Value, 2017-2027

List of Tables

Table: Global Antimicrobial Susceptibility Testing Market Size, By Product, By Value, 2017-2027     

Table: Global Antimicrobial Susceptibility Testing Market Size, By Application, By Value, 2017-2027 

Table: Global Antimicrobial Susceptibility Testing Market Size, By End-User, By Value, 2017-2027

Table: Global Antimicrobial Susceptibility Testing Market Size, By Type, By Value, 2017-2027         

Table: Global Antimicrobial Susceptibility Testing Market Size, By Method, By Value, 2017-2027               

Table: Global Antimicrobial Susceptibility Testing Market Size, By Region, By Value, 2017-2027      

Table: North America Antimicrobial Susceptibility Testing Market Size, By Product, By Value, 2017-2027         

Table: North America Antimicrobial Susceptibility Testing Market Size, By Application, By Value, 2017-2027  

Table: North America Antimicrobial Susceptibility Testing Market Size, By End-User, By Value, 2017-2027  

Table: North America Antimicrobial Susceptibility Testing Market Size, By Type, By Value, 2017-2027         

Table: North America Antimicrobial Susceptibility Testing Market Size, By Method, By Value, 2017-2027         

Table: North America Antimicrobial Susceptibility Testing Market Size, By Country, By Value, 2017-2027         

Table: Europe Antimicrobial Susceptibility Testing Market Size, By Product, By Value, 2017-2027    

Table: Europe Antimicrobial Susceptibility Testing Market Size, By Application, By Value, 2017-2027         

Table: Europe Antimicrobial Susceptibility Testing Market Size, By End-User, By Value, 2017-2027

Table: Europe Antimicrobial Susceptibility Testing Market Size, By Type, By Value, 2017-2027

Table: Europe Antimicrobial Susceptibility Testing Market Size, By Method, By Value, 2017-2027    

Table: Europe Antimicrobial Susceptibility Testing Market Size, By Country, By Value, 2017-2027    

Table: The Asia-Pacific Antimicrobial Susceptibility Testing Market Size, By Product, By Value, 2017-2027         

Table: The Asia-Pacific Antimicrobial Susceptibility Testing Market Size, By Application, By Value, 2017-2027  

Table: The Asia-Pacific Antimicrobial Susceptibility Testing Market Size, By End-User, By Value, 2017-2027  

Table: The Asia-Pacific Antimicrobial Susceptibility Testing Market Size, By Type, By Value, 2017-2027         

Table: The Asia-Pacific Antimicrobial Susceptibility Testing Market Size, By Method, By Value, 2017-2027         

Table: The Asia-Pacific Antimicrobial Susceptibility Testing Market Size, By Country, By Value, 2017-2027  

Table: Latin America Antimicrobial Susceptibility Testing Market Size, By Product, By Value, 2017-2027         

Table: Latin America Antimicrobial Susceptibility Testing Market Size, By Application, By Value, 2017-2027  

Table: Latin America Antimicrobial Susceptibility Testing Market Size, By End-User, By Value, 2017-2027         

Table: Latin America Antimicrobial Susceptibility Testing Market Size, By Type, By Value, 2017-2027         

Table: Latin America Antimicrobial Susceptibility Testing Market Size, By Method, By Value, 2017-2027         

Table: Latin America Antimicrobial Susceptibility Testing Market Size, By Country, By Value, 2017-2027         

Table: The Middle East & Africa Antimicrobial Susceptibility Testing Market Size, By Product, By Value, 2017-2027    

Table: The Middle East & Africa Antimicrobial Susceptibility Testing Market Size, By Application, By Value, 2017-2027    

Table: The Middle East & Africa Antimicrobial Susceptibility Testing Market Size, By End-User, By Value, 2017-2027    

Table: The Middle East & Africa Antimicrobial Susceptibility Testing Market Size, By Type, By Value, 2017-2027    

Table: The Middle East & Africa Antimicrobial Susceptibility Testing Market Size, By Method, By Value, 2017-2027    

Table: The Middle East & Africa Antimicrobial Susceptibility Testing Market Size, By Country, By Value, 2017-2027

 

Table: PML Microbiologicals Inc. Financial Analysis

Table: PML Microbiologicals Inc. Business Overview

Table: BioMérieux SA Financial Analysis

Table: BioMérieux SA Business Overview

Table: QuantaMatrix Inc. Financial Analysis

Table: QuantaMatrix Inc. Business Overview

Table: MP Biomedicals Financial Analysis

Table: MP Biomedicals Business Overview

Table: InvivoGen Financial Analysis

Table: InvivoGen Business Overview

Table: Biotron Ltd Financial Analysis

Table: Biotron Ltd Business Overview

Table: Becton, Dickinson and Company Financial Analysis

Table: Becton, Dickinson and Company Business Overview

Table: Thermo Fisher Scientific Financial Analysis

Table: Thermo Fisher Scientific Business Overview

Table: Danaher Corporation Financial Analysis

Table: Danaher Corporation Business Overview

Table: Roche Diagnostics Limited Financial Analysis

Table: Roche Diagnostics Limited Business Overview

Table: Bio-Rad Laboratories, Inc. Financial Analysis

Table: Bio-Rad Laboratories, Inc. Business Overview

Table: Merck KGaA Financial Analysis

Table: Merck KGaA Business Overview

Table: Accelerate Diagnostics, Inc. Financial Analysis

Table: Accelerate Diagnostics, Inc. Business Overview

Table: Liofilchem S.r.l. Financial Analysis

Table: Liofilchem S.r.l. Business Overview

Table: ZHUHAI DL BIOTECH Co., Ltd.  Financial Analysis

Table: ZHUHAI DL BIOTECH Co., Ltd.  Business Overview

Table: ELITechGroup Financial Analysis

Table: ELITechGroup Business Overview

Table: Alifax S.r.l. Financial Analysis

Table: Alifax S.r.l. Business Overview

Table: Hi-Media Laboratories Financial Analysis

Table: Hi-Media Laboratories Business Overview

Table: Genefluidics, Inc. Financial Analysis

Table: Genefluidics, Inc. Business Overview

Table: Creative Diagnostics Financial Analysis

Table: Creative Diagnostics Business Overview

 

 

 

Market Segmentation

No data available

·         By Product

o    Manual Antimicrobial Susceptibility Testing Products

§  Susceptibility Testing Disks

§  MIC Strips

§  Susceptibility Testing Plates

o    Automated Laboratory Instruments

o    Culture and Growth Media

o    Consumables

·         By Application

o    Clinical Diagnostics

o    Drug Discovery and Development

o    Epidemiology

o    Other Applications

·         By End-User

o    Hospitals and Diagnostic Centers

o    Pharmaceutical and Biotechnology Companies

o    Research &Academic Institutes

o    Clinical Research Organizations (CROs)

·         By Type

o    Antibacterial Susceptibility Testing

o    Antifungal Susceptibility Testing

o    Antiparasitic Susceptibility Testing

o    Other Susceptibility Testing Types (slow-growing pathogens)

·         By Method

o    Test Method

o    Disk Diffusion

o    Automated Susceptibility Testing Instruments

o    Agar Dilution

o    Genotyping Methods

·         By Region

o    North America

o    Europe

o    The Asia-Pacific

o    Latin America

o    The Middle East and Africa

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

This website is secure and your personal details are safe.